Core Scientific, Inc./tx (CORZZ) stock
CORZZNasdaqFinance ServicesFiscal year ends December 31Also trades as CORZ, CORZR, CORZW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 2/30223% above fair value
$12.85−1.46 (-10.20%)
Close on Oct 30, 2026Market cap $4.13BP/E –Yield –
Core Scientific operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Core Scientific's operating cash flow for the twelve months ending Jun 30, 2026 was $520.24M, up 6037.1% year over year. For fiscal 2025 it was $278.25M, up 548.7% from the year before. The highest annual figure on record is $278.25M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $278.25M | +548.7% |
| FY2024 | Dec 31, 2024 | $42.90M | -34.1% |
| FY2023 | Dec 31, 2023 | $65.11M | -68.3% |
| FY2022 | Dec 31, 2022 | $205.19M | – |
| FY2021 | Dec 31, 2021 | -$56.74M | – |
| FY2020 | Dec 31, 2020 | -$23.77M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$18.93M | -155.7% |
| Q1 FY2026 | Mar 31, 2026 | $249.88M | – |
| Q4 FY2025 | Dec 31, 2025 | $157.51M | +1041.0% |
| Q3 FY2025 | Sep 30, 2025 | $131.78M | +2206.7% |
| Q2 FY2025 | Jun 30, 2025 | $34.00M | +2723.9% |
| Q1 FY2025 | Mar 31, 2025 | -$45.04M | -303.1% |
| Q4 FY2024 | Dec 31, 2024 | $13.81M | -36.4% |
| Q3 FY2024 | Sep 30, 2024 | $5.71M | +5.1% |
| Q2 FY2024 | Jun 30, 2024 | $1.20M | -93.3% |
| Q1 FY2024 | Mar 31, 2024 | $22.17M | +11.2% |
| Q4 FY2023 | Dec 31, 2023 | $21.70M | -81.3% |
| Q3 FY2023 | Sep 30, 2023 | $5.43M | – |
| Q2 FY2023 | Jun 30, 2023 | $18.04M | -87.6% |
| Q1 FY2023 | Mar 31, 2023 | $19.94M | – |
| Q4 FY2022 | Dec 31, 2022 | $115.99M | +5.7% |
| Q3 FY2022 | Sep 30, 2022 | -$52.10M | – |
| Q2 FY2022 | Jun 30, 2022 | $144.89M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.62M | -123.5% |
| Q4 FY2021 | Dec 31, 2021 | $109.74M | – |
| Q3 FY2021 | Sep 30, 2021 | -$45.14M | – |
| Q2 FY2021 | Jun 30, 2021 | -$136.74M | – |
| Q1 FY2021 | Mar 31, 2021 | $15.41M | – |